Glucotrack Inc (GCTK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1110)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

GCTK's Discussions on Twitter

Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GCTK Glucotrack Inc	0.60	3.13M	0	-16.89M	-16.44M	-20.88
ISRG Intuitive Surgical Inc	437.67	155.16B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	148.99	40.68B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.69	33.06B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	36.13	31.30B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	208.64	30.18B	5.54B	1.52B	1.74B	10.37

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

Compare GCTK vs ISRG, BDX, ALC, MDLN, RMD

Glucotrack Inc Aktie (GCTK) Neueste Nachrichten

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - marketscreener.com

Implantable glucose sensor designed for multi-year use without wearables - Stock Titan

GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session - Sahm

GlucoTrack Faces Multiple Nasdaq Deficiency Notices, Delisting Risk - TipRanks

Glucotrack receives Nasdaq delisting notice over listing rule deficiencies By Investing.com - Investing.com South Africa

Glucotrack receives Nasdaq delisting notice over listing rule deficiencies - Investing.com

Glucotrack Received Notice of Delisting - TradingView

Glucotrack (GCTK) cited for bid price and equity Nasdaq deficiencies - Stock Titan

Armistice Capital (GCTK) reports 102,115 shares, 4.99% ownership - Stock Titan

Glucotrack Reports Q1 2026 Results and Advances IDE Submission for Implantable Glucose Monitor - Minichart

Glucotrack's 3-Year CGM Aims to Revolutionize Diabetes Management - BriefGlance

TradingKey - TradingKey

Glucotrack 1Q Loss/Shr $2.65 >GCTK - Moomoo

Glucotrack Reports Q1 2026 Net Loss of $4.3M, Cash $3.9M, Files IDE for Implantable CBGM - TradingView

Glucotrack, Inc. Q1 2026: Net loss $(4.33M), EPS $(2.65) — 10-Q Summary - TradingView

Glucotrack, Inc. Submits IDE Application to FDA for Implantable Continuous Blood Glucose Monitoring System and Reports Q1 2026 Financial Results - Quiver Quantitative

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times

GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Glucotrack (GCTK) posts Q1 loss as cash tightens and Nasdaq flags delisting - Stock Titan

Glucotrack (NASDAQ: GCTK) Q1 2026 results, IDE filing and cash runway - Stock Titan

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire Inc.

GlucoTrack Stock Short Interest Rises to 59.4% - Moomoo

What you need to know before buying GlucoTrack (GCTK) (+0.76%) 2026-05-08Mid Cap Momentum - newser.com

How GlucoTrack (GCTK) maintains its asset base | GCTK: GlucoTrack Q Results Lack Revenue, EPS DataFinancial Summary - newser.com

GlucoTrack Files IDE for Implantable Glucose Monitor - TipRanks

IDE filing advances Glucotrack (NASDAQ: GCTK) implantable glucose monitor - Stock Titan

Glucotrack Submits Blood Glucose Monitoring Technology to FDA - Yahoo Finance

Glucotrack Submits IDE Application for U.S. Clinical Study of Its Implantable Continuous Blood Glucose Monitoring System - citybiz

Glucotrack Submits IDE to FDA for Implantable Continuous Blood Glucose Monitoring System - geneonline.com

Glucotrack submits FDA application for implantable glucose monitor - Investing.com

Glucotrack submits FDA application for implantable glucose monitor By Investing.com - Investing.com Canada

GlucoTrack, Inc. announced it has officially submitted an Investigational Device Exemption (IDE) application to US regulators for its innovative implantable continuous glucose monitoring technology. - Bitget

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology - The Manila Times

Glucotrack, Inc. Submits Investigational Device Exemption Application to FDA for Continuous Blood Glucose Monitoring Technology - Quiver Quantitative

Implantable diabetes monitor moves toward U.S. trial without a wearable - Stock Titan

Glucotrack Announces IDE Submission for U.S. Clinical Study of Its Novel Implantable Continuous Blood Glucose Monitoring Technology - Moomoo

GCTK Stock Jumps As Implantable CGM Data Impresses - StocksToTrade

GCTK Jumps As GlucoTrack’s Implantable CGM Data Impresses - timothysykes.com

$Glucotrack (GCTK.US)$ no bad。 sell it now - Moomoo

see if this zone is the one. $Glucotrack (GCTK.US)$ - Moomoo

GCTK SEC FilingsGlucotrack 10-K, 10-Q, 8-K Forms - Stock Titan

Needle-free diabetes care: 6 devices that painlessly monitor blood sugar - Labiotech.eu

GlucoTrack Executes Debt-for-Equity Exchange and Investor Update - The Globe and Mail

GlucoTrack Reports Strong Preclinical Data for Implantable CBGM - The Globe and Mail

Peer-Reviewed Study in Journal of Diabetes Research Verifies Glucotrack’s Long‑Term Continuous Blood Glucose Monitoring Technology - citybiz

[EFFECT] Glucotrack, Inc. SEC Filing - Stock Titan

Glucotrack (NASDAQ: GCTK) swaps $988K debt for 1.3M new shares - Stock Titan

Glucotrack publishes 240-day glucose monitor study results By Investing.com - Investing.com South Africa

Finanzdaten der Glucotrack Inc-Aktie (GCTK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie GCTK